Canopy Growth Corporation reported CA$81.2 million in net revenue for its first quarter of fiscal year 2027, an increase of 13% compared to the same period last year, with revenue growth across each of its major business segments. Cannabis net revenue reached CA$65.1 million for the three months ended June 30, up 14% from CA$57 million a year earlier. Canadian medical cannabis generated CA$25.8 million in net revenue, a 22% year-over-year increase. Canadian adult-use cannabis revenue increased 10% to CA$29.7 million, driven primarily by higher flower sales following the MTL Cannabis acquisition. International cannabis revenue also increased 10%, reaching CA$9.6 million, with the company pointing to strength in Europe, particularly Poland.